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Abstract  
Iodine is an essential nutrient for the production of thyroid hormones triiodothyronine (T3) and thyroxine (T4). A woman needs 
more iodine during pregnancy to maintain normal metabolism as well as to meet the requirements of T4 and iodide transfer to the 
fetus. Objective of this study was to assess the thyroid status among newborns in Jaffna District, because similar studies 
conducted nationally, but not in Jaffna and no data is available about the thyroid status of the neonates. Randomly selected 477 
newborns in six Medical Officers of Health (MOH) Divisions out of twelve were studied.Blood spots were taken from the 
neonates within the one week of delivery on specified filter paper and thyroid stimulating hormone (TSH) was assayed by using 
enzyme-linked immunosorbent assay(ELISA)/Radioimmunoassay (RIA) technique depending on availability of the kits in the 
laboratory. Among the total newborns, 239 were males (50.5%). Mean birth weight (BW) of them was 3031.5(±432.6) g, while 
the mean length was 51.1 (±2.1) cm. BW of males ranged from 1.7 to 5.0 Kg and of females from 1.5 to 4.35 Kg. Length of the 
newborns ranged from 45.0 to 58.0 cm for males and from 44.0 to 57.0 cm for females. The low birth weight (LBW), normal 
birth weight (NBW) and higher birth weight (HBW) were 11.3 (n=54), 88.5 (n=422) and 0.2 % (n=1) respectively. Mean 
neonatal blood spot TSH concentration was 9.8 (±2.1) mIU/L, and ranged from 1.00 to 53.46 mIU/L. Neonatal TSH level of the 
entire blood spot was categorized as > 20 mIU/L and < 20 mIU/L and the blood spot TSH > 20 mIU/L was considered as positive 
for congenital hypothyroidism. Among the newborns, 18% (n=86) of them were identified as positive with 10 % males and 8% 
females. Only one newborn was diagnosed as being congenitally hypothyroid (serum TSH >9.8 mIU/L and free T4< 10 pmol/L) 
with very high blood spot TSH value of 360.91 mIU/L. Further, a higher prevalence (37.7%) of neonates with blood spot TSH >5 
mIU/Lwas observed in this study. 
© 2016 The Authors. Published by Elsevier Ltd. 
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2015 (ICSUSL 2015). 
Keywords:Thyroid hormone; congenital hypothyroidism; newborns; birth weight  
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Peer-review under responsibility of International Conference of Sabaragamuwa University of Sri Lanka 2015 (ICSUSL 2015).
272   T. Yoganathan et al. /  Procedia Food Science  6 ( 2016 )  271 – 274 
1. Introduction 
 
Iodine is an essential nutrient for the production of the thyroid hormones, triiodothyronine (T3) and thyroxine (T4). 
A woman needs more iodine during pregnancy to maintain normal metabolism as well as to meet the requirements 
of T4 and iodide transfer to the fetus. An insufficient supply of thyroid hormones to the developing brain of the fetus 
can result in congenital anomalies and intellectual impairment1. Further, symptoms and signs of congenital 
hypothyroidism (CH) are often non-specific unless tested biochemically, and CH will be frequently overlooked, 
resulting in irreparable neurological damage caused by thyroid hormone deficiency during this crucial period of 
brain development. For early detection and implementation of thyroid hormone therapy, systematic screening 
programs for neonatal thyroid function were introduced in many countries in the early 1970s2,3. The initial screening 
method was measurement of T4 by heel-prick blood spots sample. This has been superseded by measurement of 
thyroid stimulating hormone (TSH) level in most programmes around the world including in Sri Lanka.  The major 
inconvenience in measurement of serum TSH level is that it is unable to detect central (hypothalamic or pituitary) 
hypothyroidism, a rare disorder occurring in approximately 1 in 20 000 neonates, which can be picked up only by 
doing T4 test.  Serum TSH assay can detect the subclinical or transient primary hypothyroidism that can be missed 
by T4 assay in screening programs for CH4.  The incidence of CH has been reported as 1 in 1500 to 1 in 2000 live 
births in Southern part of Sri Lanka between 2011 and 20125. Decline in incidence may be due to the improved 
knowledge of pregnant mothers on iodine nutrition by health education in antennal clinics. Only few studies have 
been published on the thyroid statusof the newborns in Sri Lanka by assessing the neonatal TSH level.  Further, after 
the implementation of the universal salt iodization program in Sri Lanka there have not been any published data on 
thyroid function among the newborns. Also, iodine supplementation during pregnancy is not a routine practice in Sri 
Lanka. Policy makers might be thinking that salt iodization is adequate to provide optimum iodine nutrition to the 
population. Therefore, this study was carried out to assess the thyroid status among newborns in Jaffna 
District.Although some similar studies have been conducted nationally, there are no data available about the thyroid 
status of the neonates in Jaffna district. 
 
2. Methodology 
Four hundred and seventy seven newborns of the randomly selected pregnant mothers in six (Jaffna, Uduvil, Nallur, 
Kopay, Karaveddy and Kays) Medical Officers of Health (MOH) Divisions out of twelve were included for this 
study during the period 2012/2013. Newborns were selected randomly with probability proportion to the number of 
deliveries occurred in the previous year of this study conducted. Ethical approval was obtained from Ethical Review 
Committee of the Faculty of Medicine, University of Jaffna. Results were presented by using descriptive statistics as 
mean (±standard deviation), percentage and frequency. Simple linear regression analysis was used to test the 
correlations between blood spot TSH and BW of the newborn. Weight of the newborn was measured by digital 
infant scale to the precision of 10 g with wearing nappies or only light clothing. First the “zero” level of scale was 
adjusted. Next the newborn was put on the weighing pan of the digital infant scale. The weighing scale was checked 
every morning prior to the use. The recumbent length of the infants was measured by using portable infantometer 
(SECA 417, Germany) with a precision of 0.1 cm. Further, examination was carried out and a heel prick blood spot 
(by filter paper) was collected from the neonate prior to the discharge.  If the blood spot were not obtained from the 
newborn before the discharge from the hospital, spots were collected through home visits within a week of delivery.  
The cut- off values for TSH were decided depending on the age of the newborn at the time of blood spot collection 
and it was 40.0 mIU/L upto 48 hrs (i.e., Day 2) and 20.0 mIU/L after 48 hrs of life (i.e., Day 3 onwards). These 
values were based on the analysis of a pilot study done at Southern Province of Sri Lanka 
(Hettiarachchi&Amarasena, 2014). The blood spot TSH analyses were done using the IMMUCHEM™ 
NEONATAL TSH-MW ELISA (bulk kit −20 plates) and radioimmunoassay (RIA) kits (500 tubes kit) provided by 
MP Biochemicals, USA on availability of the kits in the laboratory. Once a positive case was found a repeat test was 
performed to confirm results. For that, the parents were contacted immediately through telephone in order to get a 
serum sample for the confirmation of the disease. Both serum TSH and free T4 were determined in these newborns 
using respective enzyme-linked immunosorbent assay (ELISA) kits provided by the MP Biochemicals, USA. CH 
was confirmed if serum TSH >9.8 mIU/L and free T4< 10 pmol/L Data were presented as descriptive statics mean± 
SD, range, frequency and percentage. The coefficients of variation of the intra-assays was 5.5%, whereas inter-assay 
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was 4.5%. The lower limit of detection was 0.01 μIU/mL. Intra-assay precision was below 0.50% and inter-assay 
coefficient variation was 2.0%. 
 
3. Results 
 
3.1 Characteristics of the newborns 
 
Newborns characteristics and their thyroid status are given in Table 1. Among the 477 newborns, 239 were males 
(50.5%). Mean BW of them was 3031.5(±432.6) g, while the mean length was 51.1 (±2.1) cm. BW of males ranged 
from 1.7 to 5.0 Kg and of females from 1.5 to 4.35 Kg. Length of the newborns ranged from 45.0 to 58.0 cm for 
males and from 44.0 to 57.0 cm for females. BW was categorized into LBW (<2500 g), NBW (2500-4500 g) and 
HBW (>4500 g). The LBW, NBW and HBW were 11.3 (n=54), 88.5 (n=422) and 0.2 % (n=1) respectively.  
Further, among the total of 477 newborns, 68.1 % were normal delivery and rest of them via caesarean.   
 
3.2 Neonatal TSH and congenital hypothyroidism 
 
Mean neonatal blood spot TSH concentration of 477 subjects was 9.8 (±2.1)mIU/L, and ranged from 1.00 to 53.46 
mIU/L. According to the guidelines of International Atomic Energy Agency (IAEA), neonatal TSH level of the 
blood spot was categorized > 20 mIU/L and < 20 mIU/L.  The serum TSH > 20 mIU/L is considered as positive for 
congenital hypothyroidism. Among the newborns, 18% (n86) of them were identified as positive with 10 % males 
and 8% females. The recall rate was less than 1.0 %, and only one newborn was diagnosed as being congenitally 
hypothyroid with very high TSH value of 360.91 mIU/L during the study period from May 2012 to December 2013. 
CH was confirmed finally, newborn was referred for treatment to a paediatrician. Neonatal blood spot TSH level 
was not significantly correlated with BW of the newborn (p=0.11, r=0.78). 
 
Table 1: Newborns ‘characteristics and blood spots TSH level 
Newborn’s parameter 
Male Female Over all 
% (Number) 
Sex 50.5 (239) 49.5 (238) 100 (477) 
Birth Weight (Kg)        mean(range) 3.06 (1.70 -5.00) 3.00 (1.50 – 4.35) 3.03 (1.50 – 5.00) 
Length (cm)                  mean(range) 51.2 (45.0-58.0) 50.9 (44.0-57.0) 51.1 (44.0-58.0) 
LBW                                        % (n) 5.0 (24) 6.3 (30) 11.3 (54) 
NBW                                       % (n) 46.3 (221) 42.2 (201) 88.5 (422) 
HBW                                       % (n) 0.2 (1) 0 (0) 0.2 (1) 
Blood spot TSH ˂20.0  mIU/L 40.0 (191) 42.0 (200) 82.0 (391) 
˃20.0  mIU/L 10.0 (48) 8.0 (38) 18.0 (86) 
 
 
3. Discussion 
Neonatal blood spot TSH level of hypothyroid baby was very high (361.9 mIU/L) and it was detected by blood spot 
analysis. This assay may be used to identify neonates with congenital hypothyroidism caused by lack of maternal 
iodine nutrition.  The reason for this association would be the lack iodine intake during pregnancy and may have 
induced the elevated TSH in neonates.  In Sri Lanka, the incidence rate of CH is much higher when compared to the 
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rest of the countries in South Asia, although published reports have been limited nationally.  In a study conducted in 
Southern part of the country in 2011- 2012, a total of 78,167 newborns (99.0% of live births) were screened for CH. 
The incidence of primary CH among screened newborns was 1:1682 and the number of true positive cases and 
consequently the incidence rate of CH increased from 1:1800 in 2011 to 1:1500 in 20125. The frequency of 
permanent CH varies in different countries. Recent studies in India expressed a prevalence of CH as approximately 
1:11006. In Iran the incident rate of CH was 1 in 895 live births, whereas the corresponding rates in Tehran and 
Damavand were about 1 in 9507.  Another study conducted with 93381 neonates in Iran showed that the prevalence 
of CH was l in 349 live births.  But, the worldwide the prevalence of CH was reported as 1 in 3000–4000 live 
births7.But, this present study indicated that higher prevalence rate of CH observed in Jaffna District. However, this 
study had some potential limitations. The sample size was relatively small and may not be adequate for calculation 
of a true prevalence of CH. Therefore, these results need to be reassessed with a larger number of study samples in 
same study area. Considering this high incidence rate of CH, availability of low cost therapy and a robust screening 
test like blood spot TSH, is highly desirable to start a screening program in entire Northern Province to prevent the 
most preventable cause of mental sub normality. 
Further, utilization of neonatal TSH is an attractive method because it is assumed that the thyroid of the newborn is 
very sensitive to iodine status and even mild iodine deficiency during pregnancy will cause an increase in neonatal 
TSH secretion. In addition in countries where such screening programme exists, the utilization of neonatal TSH 
levels does not imply an extra cost. Unfortunately in most of the regions where iodine deficiency is severe such 
screening programs are usually lacking. In Sri Lanka however the situation is different because there are two 
screening centres in Central Province and Southern Province using two different assay methods (ELISA and RIA). 
Despite this heterogeneity and after applying correction factors for time sampling, the centre showed concordant 
values indicating a low frequency of TSH  >20 mIU/L. 
 
4. Conclusion 
The prevalence of CH was high in Jaffna District and higher prevalence (37.7%) of neonates with blood spot TSH 
>5 mIU/Lwas observed in this study. 
 
5. References 
1. Delange F. Optimal iodine nutrition during pregnancy, lactation and the neonatal period.Int J EndocrinolMetab; 2004; 2: 1-12. 
2. Delange F. Neonatal screening for congenital hypothyroidism: results and perspectives. Hormone Research; 1997; 48: 51–61. 
3. Dussault JH. The anecdotal history of screening for congenital hypothyroidism.Journal of Clinical Endocrinology and Metabolism; 1999.84: 
4332–4. 
4. Foley T, Kaplowitz PB, Kaye CI. Update of newborn screening and therapy for congenital hypothyroidism. American Academy of Pediatrics, 
Rose SR, Section on Endocrinology and Committee on Genetics, American Thyroid Association, Brown RS, Public Health Committee, 
Lawson Wilkins Pediatric Endocrine Society, Pediatrics; 2006; 117: 2290–303. 
5. Hettiarachch M, Amarasena S. Indicators of newborn screening for congenital hypothyroidism in Sri Lanka: program challenges and way 
forward, BMC Health Services Research, 2014; 14:385. 
6. Mathai S. Newborn screening for congenital hypothyroidism- experience from India. Abstract presented at 8th Asia Pacific Regional Meeting  
of the International Society for Neonatal Screening; 2013; New Delhi. 
7. Ordookhani A, Mirmiran P, Moharamzadeh MA. high prevalence of consanguineous and severe congenital hypothyroidism in an Iranian 
population.J PediatrEndocrinolMetab; 2004; 17(9):1201-9. 
